- Home
- PRTA vs FFC Comparison
PRTA vs FFC Comparison
Compare PRTA & FFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTA
- FFC
- Stock Information
- Founded
- PRTA 2012
- FFC 1983
- Country
- PRTA Ireland
- FFC United States
- Employees
- PRTA N/A
- FFC N/A
- Industry
- PRTA Biotechnology: Pharmaceutical Preparations
- FFC Trusts Except Educational Religious and Charitable
- Sector
- PRTA Health Care
- FFC Finance
- Exchange
- PRTA Nasdaq
- FFC Nasdaq
- Market Cap
- PRTA 809.8M
- FFC 767.5M
- IPO Year
- PRTA N/A
- FFC N/A
- Fundamental
- Price
- PRTA $12.14
- FFC $16.01
- Analyst Decision
- PRTA Buy
- FFC
- Analyst Count
- PRTA 9
- FFC 0
- Target Price
- PRTA $54.57
- FFC N/A
- AVG Volume (30 Days)
- PRTA 454.8K
- FFC 164.1K
- Earning Date
- PRTA 05-07-2025
- FFC 01-01-0001
- Dividend Yield
- PRTA N/A
- FFC 6.79%
- EPS Growth
- PRTA N/A
- FFC N/A
- EPS
- PRTA N/A
- FFC N/A
- Revenue
- PRTA $135,157,000.00
- FFC N/A
- Revenue This Year
- PRTA N/A
- FFC N/A
- Revenue Next Year
- PRTA $131.75
- FFC N/A
- P/E Ratio
- PRTA N/A
- FFC N/A
- Revenue Growth
- PRTA 47.92
- FFC N/A
- 52 Week Low
- PRTA $11.42
- FFC $11.90
- 52 Week High
- PRTA $25.42
- FFC $14.96
- Technical
- Relative Strength Index (RSI)
- PRTA 38.46
- FFC 50.32
- Support Level
- PRTA $11.42
- FFC $15.83
- Resistance Level
- PRTA $13.52
- FFC $16.06
- Average True Range (ATR)
- PRTA 0.75
- FFC 0.14
- MACD
- PRTA -0.12
- FFC -0.01
- Stochastic Oscillator
- PRTA 24.66
- FFC 43.18
About PRTA Prothena Corporation plc
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).
About FFC Flaherty & Crumrine Preferred and Income Securities Fund Incorporated
Flaherty & Crumrine Preferred and Income Securities Fund Incorporated is a diversified, closed-end management investment company. The fund's investment objective is to provide its common shareholders with high current income consistent with the preservation of capital. It invests in a diversified portfolio of preferred securities.